Opening book details…
About this Biochemistry, Genetics and Molecular Biology article
Outcomes of patients with sarcoma enrolled in clinical trials of pazopanib combined with histone deacetylase, mTOR, Her2, or MEK inhibitors by Dembla, Vikas; Groisberg, Roman; Hess, Ken; Fu, Siqing; Wheler, Jennifer; Hong, David S.; Janku, Filip; Zinner, Ralph; Piha-Paul, Sarina Anne; Ravi, Vinod; Benjamin, Robert S.; Patel, Shreyaskumar; Somaiah, Neeta; Herzog, Cynthia E.; Karp, Daniel D.; Roszik, Jason; Meric-Bernstam, Funda; Subbiah, Vivek is a Biochemistry, Genetics and Molecular Biology article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Biochemistry, Genetics and Molecular Biology.
- Author
- Dembla, Vikas; Groisberg, Roman; Hess, Ken; Fu, Siqing; Wheler, Jennifer; Hong, David S.; Janku, Filip; Zinner, Ralph; Piha-Paul, Sarina Anne; Ravi, Vinod; Benjamin, Robert S.; Patel, Shreyaskumar; Somaiah, Neeta; Herzog, Cynthia E.; Karp, Daniel D.; Roszik, Jason; Meric-Bernstam, Funda; Subbiah, Vivek
- Publisher
- Springer Science and Business Media LLC; London: Nature Publishing Group; [London]: Springer Nature; Nature Publishing Group; Society for Mining, Metallurgy and Exploration Inc.; Research Square; Springer Nature; Island Press (ISSN 2045-2322)
- Published
- 2017
- Field
- Biochemistry, Genetics and Molecular Biology (Life Sciences)